<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interleukin-1 (IL-1) synthesis in the brain is stimulated by mechanical injury and IL-1 mimics some effects of injury, such as <z:hpo ids='HP_0002171'>gliosis</z:hpo> and neovascularization </plain></SENT>
<SENT sid="1" pm="."><plain>We report that neuronal <z:hpo ids='HP_0011420'>death</z:hpo> resulting from focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> (middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, 24 h) is significantly inhibited (by 50%) in rats injected with a recombinant IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (IL-1ra, 10 micrograms, icv 30 min before and 10 min after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Excitotoxic damage due to striatal infusion of an <z:chebi fb="0" ids="31882">NMDA</z:chebi>-receptor <z:chebi fb="4" ids="48705">agonist</z:chebi> (cis-2,4-methanoglutamate) was also markedly inhibited (71%) by injection of the IL-1ra </plain></SENT>
<SENT sid="3" pm="."><plain>These data indicate that endogenous IL-1 is a mediator of ischaemic and excitotoxic brain damage, and that inhibitors of IL-1 action may be of therapeutic value in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>